English

HAEMONETICS CORPORATION

EDGAR

HAE Quarterly report (10-Q) · filed 2026-08-06

Annual consolidated revenue for 2026: about USD 1.334B, using the latest reported figures. The previous period, 2025, was about USD 1.361B.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

339 million USD

2026-06-27 · USD

Exact inputs and evidence

Revenue: 339380000 USD Source

Operating margin

16.93%

2026-06-27 · %

Exact inputs and evidence

Operating Income: 57458000 USD Source
Revenue: 339380000 USD Source

Operating cash flow

52.3 million USD

2026-06-27 · USD

Exact inputs and evidence

Operating Cash Flow: 52323000 USD Source

Free cash flow

44.4 million USD

2026-06-27 · USD

Exact inputs and evidence

Operating Cash Flow: 52323000 USD Source
Capital Expenditure: 7906000 USD Source

Cash and cash equivalents: 223 million USD 2026-06-27 Source
Exact value

223384000 USD
Long-term debt including current maturities: 1.19 billion USD 2026-06-27 Source
Exact value

1188202000 USD
Shares outstanding: 45.5 million shares 2026-06-27 Source
Exact value

45471313 shares

Reported share-count change

-5.58% · -2.69 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

48158723 shares · 2025-06-28· Source
45471313 shares · 2026-06-27· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.35 billion USD

2025-06-29 – 2026-06-27

Exact inputs and evidence

Revenue: 327315000 USD · 2025-06-29 – 2025-09-27 Source
Revenue: 338967000 USD · 2025-09-28 – 2025-12-27 Source
Revenue: 1334027000 USD · 2025-03-30 – 2026-03-28 Source
Revenue: 987676000 USD · 2025-03-30 – 2025-12-27 Source
Revenue: 339380000 USD · 2026-03-29 – 2026-06-27 Source

Net income

96.3 million USD

2025-06-29 – 2026-06-27

Exact inputs and evidence

Net income: 38684000 USD · 2025-06-29 – 2025-09-27 Source
Net income: 44740000 USD · 2025-09-28 – 2025-12-27 Source
Net income: 97308000 USD · 2025-03-30 – 2026-03-28 Source
Net income: 117455000 USD · 2025-03-30 – 2025-12-27 Source
Net income: 33010000 USD · 2026-03-29 – 2026-06-27 Source

Operating cash flow

328 million USD

2025-06-29 – 2026-06-27

Exact inputs and evidence

Operating cash flow: 128716000 USD · 2025-03-30 – 2025-09-27 Source
Operating cash flow: 17395000 USD · 2025-03-30 – 2025-06-28 Source
Operating cash flow: 222280000 USD · 2025-03-30 – 2025-12-27 Source
Operating cash flow: 128716000 USD · 2025-03-30 – 2025-09-27 Source
Operating cash flow: 293221000 USD · 2025-03-30 – 2026-03-28 Source
Operating cash flow: 222280000 USD · 2025-03-30 – 2025-12-27 Source
Operating cash flow: 52323000 USD · 2026-03-29 – 2026-06-27 Source

Capital expenditure

36.9 million USD

2025-06-29 – 2026-06-27

Exact inputs and evidence

Capital expenditure: 8770000 USD · 2025-03-30 – 2025-09-27 Source
Capital expenditure: 3754000 USD · 2025-03-30 – 2025-06-28 Source
Capital expenditure: 15119000 USD · 2025-03-30 – 2025-12-27 Source
Capital expenditure: 8770000 USD · 2025-03-30 – 2025-09-27 Source
Capital expenditure: 32780000 USD · 2025-03-30 – 2026-03-28 Source
Capital expenditure: 15119000 USD · 2025-03-30 – 2025-12-27 Source
Capital expenditure: 7906000 USD · 2026-03-29 – 2026-06-27 Source

Free cash flow

291 million USD

2025-06-29 – 2026-06-27

Exact inputs and evidence

Operating cash flow: 128716000 USD · 2025-03-30 – 2025-09-27 Source
Operating cash flow: 17395000 USD · 2025-03-30 – 2025-06-28 Source
Operating cash flow: 222280000 USD · 2025-03-30 – 2025-12-27 Source
Operating cash flow: 128716000 USD · 2025-03-30 – 2025-09-27 Source
Operating cash flow: 293221000 USD · 2025-03-30 – 2026-03-28 Source
Operating cash flow: 222280000 USD · 2025-03-30 – 2025-12-27 Source
Operating cash flow: 52323000 USD · 2026-03-29 – 2026-06-27 Source
Capital expenditure: 8770000 USD · 2025-03-30 – 2025-09-27 Source
Capital expenditure: 3754000 USD · 2025-03-30 – 2025-06-28 Source
Capital expenditure: 15119000 USD · 2025-03-30 – 2025-12-27 Source
Capital expenditure: 8770000 USD · 2025-03-30 – 2025-09-27 Source
Capital expenditure: 32780000 USD · 2025-03-30 – 2026-03-28 Source
Capital expenditure: 15119000 USD · 2025-03-30 – 2025-12-27 Source
Capital expenditure: 7906000 USD · 2026-03-29 – 2026-06-27 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-06.

Financial data available through: 2026-03-28.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2026-03-28
Operating income: 11 of 11 periods available· newest 2026-03-28
Net income: 11 of 11 periods available· newest 2026-03-28
Operating cash flow: 11 of 11 periods available· newest 2026-03-28
Capital expenditure: 11 of 11 periods available· newest 2026-03-28
Total assets: 5 of 11 periods available· newest 2026-03-28
liabilities: No compatible figures in this window
Current assets: 5 of 11 periods available· newest 2026-03-28
Current liabilities: 5 of 11 periods available· newest 2026-03-28
Cash and cash equivalents: 5 of 11 periods available· newest 2026-03-28
Long-term debt including current maturities: 2 of 11 periods available· newest 2026-03-28
Shares outstanding: 5 of 11 periods available· newest 2026-03-28

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-2%

Prior period

USD 1.36 billion

2024-03-31 – 2025-03-29
Current period

USD 1.33 billion

2025-03-30 – 2026-03-28

Exact inputs and evidence

1334027000 − 1360824000 = -26797000 USD

1360824000 USD · 2024-03-31 – 2025-03-29
Inspect prior input Prior source
1334027000 USD · 2025-03-30 – 2026-03-28
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · HAEMONETICS CORPORATION · 2026-03-28 HAEMONETICS CORPORATION (edgar:313143) Year-over-year change in Revenue: -26797000 USD Concept: fundies:Revenue Period: 2025-03-30 to 2026-03-28 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1334027000 USD (2025-03-30 to 2026-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#2601179 Filing: 000031314326000050 Input fundies:Revenue: 1360824000 USD (2024-03-31 to 2025-03-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#2602213 Filing: 000031314326000050
The citation records this snapshot. The page link may show a newer release later.
Net income
-42%

Prior period

USD 167.68 million

2024-03-31 – 2025-03-29
Current period

USD 97.31 million

2025-03-30 – 2026-03-28

Exact inputs and evidence

97308000 − 167679000 = -70371000 USD

167679000 USD · 2024-03-31 – 2025-03-29
Inspect prior input Prior source
97308000 USD · 2025-03-30 – 2026-03-28
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · HAEMONETICS CORPORATION · 2026-03-28 HAEMONETICS CORPORATION (edgar:313143) Year-over-year change in Net income: -70371000 USD Concept: fundies:NetIncome Period: 2025-03-30 to 2026-03-28 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 97308000 USD (2025-03-30 to 2026-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1778783 Filing: 000031314326000050 Input fundies:NetIncome: 167679000 USD (2024-03-31 to 2025-03-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1779552 Filing: 000031314326000050
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+61.4%

Prior period

USD 181.73 million

2024-03-31 – 2025-03-29
Current period

USD 293.22 million

2025-03-30 – 2026-03-28

Exact inputs and evidence

293221000 − 181725000 = 111496000 USD

181725000 USD · 2024-03-31 – 2025-03-29
Inspect prior input Prior source
293221000 USD · 2025-03-30 – 2026-03-28
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · HAEMONETICS CORPORATION · 2026-03-28 HAEMONETICS CORPORATION (edgar:313143) Year-over-year change in Operating cash flow: 111496000 USD Concept: fundies:OperatingCashFlow Period: 2025-03-30 to 2026-03-28 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 293221000 USD (2025-03-30 to 2026-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1150419 Filing: 000031314326000050 Input fundies:OperatingCashFlow: 181725000 USD (2024-03-31 to 2025-03-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1151073 Filing: 000031314326000050
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-16.5%

Prior period

USD 39.28 million

2024-03-31 – 2025-03-29
Current period

USD 32.78 million

2025-03-30 – 2026-03-28

Exact inputs and evidence

32780000 − 39278000 = -6498000 USD

39278000 USD · 2024-03-31 – 2025-03-29
Inspect prior input Prior source
32780000 USD · 2025-03-30 – 2026-03-28
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · HAEMONETICS CORPORATION · 2026-03-28 HAEMONETICS CORPORATION (edgar:313143) Year-over-year change in Capital expenditure: -6498000 USD Concept: fundies:CapitalExpenditure Period: 2025-03-30 to 2026-03-28 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 32780000 USD (2025-03-30 to 2026-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1153660 Filing: 000031314326000050 Input fundies:CapitalExpenditure: 39278000 USD (2024-03-31 to 2025-03-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1154251 Filing: 000031314326000050
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2026 2025-03-30 – 2026-03-28

Revenue USD 1.33 billion 100% of revenue
Cost of revenue USD 546.44 million 41% of revenue
Operating expenses USD 630.85 million 47% of revenue
Operating income USD 156.73 million 12% of revenue
Tax, interest and other Derived USD 59.43 million 4.5% of revenue
Net income USD 97.31 million 7.3% of revenue

Cash

Operating cash flow USD 293.22 million 22% of revenue
Capital expenditure USD 32.78 million 2.5% of revenue
Free cash flow Derived USD 260.44 million 20% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2022 92%
2023 9.9%87%
2024 87%
2025 12%84%
2026 88%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2022 2021-04-04 – 2022-04-02	993196000	912446000 Derived	80750000	37375000 Derived	43375000	75754000 Derived	Source 2021-04-04 – 2022-04-02: 993196000 USD Inspect Revenue Open source 2021-04-04 – 2022-04-02: 80750000 USD Inspect Operating Income Open source 2021-04-04 – 2022-04-02: 43375000 USD Inspect Net Income Open source 2021-04-04 – 2022-04-02: 172263000 USD Inspect Operating Cash Flow Open source 2021-04-04 – 2022-04-02: 96509000 USD Inspect Capital Expenditure Open source
2023 2022-04-03 – 2023-04-01	1168660000	1012627000 Derived	156033000	40632000 Derived	115401000	81731000 Derived	Source 2022-04-03 – 2023-04-01: 1168660000 USD Inspect Revenue Open source 2022-04-03 – 2023-04-01: 156033000 USD Inspect Operating Income Open source 2022-04-03 – 2023-04-01: 115401000 USD Inspect Net Income Open source 2022-04-03 – 2023-04-01: 273058000 USD Inspect Operating Cash Flow Open source 2022-04-03 – 2023-04-01: 191327000 USD Inspect Capital Expenditure Open source
2024 2023-04-02 – 2024-03-30	1309055000	1144172000 Derived	164883000	47325000 Derived	117558000	143626000 Derived	Source 2023-04-02 – 2024-03-30: 1309055000 USD Inspect Revenue Open source 2023-04-02 – 2024-03-30: 164883000 USD Inspect Operating Income Open source 2023-04-02 – 2024-03-30: 117558000 USD Inspect Net Income Open source 2023-04-02 – 2024-03-30: 181751000 USD Inspect Operating Cash Flow Open source 2023-04-02 – 2024-03-30: 38125000 USD Inspect Capital Expenditure Open source
2025 2024-03-31 – 2025-03-29	1360824000	1139007000 Derived	221817000	54138000 Derived	167679000	142447000 Derived	Source 2024-03-31 – 2025-03-29: 1360824000 USD Inspect Revenue Open source 2024-03-31 – 2025-03-29: 221817000 USD Inspect Operating Income Open source 2024-03-31 – 2025-03-29: 167679000 USD Inspect Net Income Open source 2024-03-31 – 2025-03-29: 181725000 USD Inspect Operating Cash Flow Open source 2024-03-31 – 2025-03-29: 39278000 USD Inspect Capital Expenditure Open source
2026 2025-03-30 – 2026-03-28	1334027000	1177293000 Derived	156734000	59426000 Derived	97308000	260441000 Derived	Source 2025-03-30 – 2026-03-28: 1334027000 USD Inspect Revenue Open source 2025-03-30 – 2026-03-28: 156734000 USD Inspect Operating Income Open source 2025-03-30 – 2026-03-28: 97308000 USD Inspect Net Income Open source 2025-03-30 – 2026-03-28: 293221000 USD Inspect Operating Cash Flow Open source 2025-03-30 – 2026-03-28: 32780000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.3B 2026

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20222022-04-02	Revenue	993196000	Revenue: 993196000 Open source
20232023-04-01	Revenue	1168660000	Revenue: 1168660000 Open source
20242024-03-30	Revenue	1309055000	Revenue: 1309055000 Open source
20252025-03-29	Revenue	1360824000	Revenue: 1360824000 Open source
20262026-03-28	Revenue	1334027000	Revenue: 1334027000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-2% 2026

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20222022-04-02	Year over year	No prior comparable period	Revenue: 993196000 Open source
20232023-04-01	Year over year	17.7%	Revenue: 1168660000 Open source Revenue: 993196000 Open source
20242024-03-30	Year over year	12%	Revenue: 1309055000 Open source Revenue: 1168660000 Open source
20252025-03-29	Year over year	4%	Revenue: 1360824000 Open source Revenue: 1309055000 Open source
20262026-03-28	Year over year	-2%	Revenue: 1334027000 Open source Revenue: 1360824000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 11.7% 2026

Net margin 7.3% 2026

Free cash flow margin 19.5% 2026

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20222022-04-02	Operating margin	8.1%	Operating Income: 80750000 Open source Revenue: 993196000 Open source
20232023-04-01	Operating margin	13.4%	Operating Income: 156033000 Open source Revenue: 1168660000 Open source
20242024-03-30	Operating margin	12.6%	Operating Income: 164883000 Open source Revenue: 1309055000 Open source
20252025-03-29	Operating margin	16.3%	Operating Income: 221817000 Open source Revenue: 1360824000 Open source
20262026-03-28	Operating margin	11.7%	Operating Income: 156734000 Open source Revenue: 1334027000 Open source
20222022-04-02	Net margin	4.4%	Net Income: 43375000 Open source Revenue: 993196000 Open source
20232023-04-01	Net margin	9.9%	Net Income: 115401000 Open source Revenue: 1168660000 Open source
20242024-03-30	Net margin	9%	Net Income: 117558000 Open source Revenue: 1309055000 Open source
20252025-03-29	Net margin	12.3%	Net Income: 167679000 Open source Revenue: 1360824000 Open source
20262026-03-28	Net margin	7.3%	Net Income: 97308000 Open source Revenue: 1334027000 Open source
20222022-04-02	Free cash flow margin	7.6%	Revenue: 993196000 Open source Operating Cash Flow: 172263000 Open source Capital Expenditure: 96509000 Open source
20232023-04-01	Free cash flow margin	7%	Revenue: 1168660000 Open source Operating Cash Flow: 273058000 Open source Capital Expenditure: 191327000 Open source
20242024-03-30	Free cash flow margin	11%	Revenue: 1309055000 Open source Operating Cash Flow: 181751000 Open source Capital Expenditure: 38125000 Open source
20252025-03-29	Free cash flow margin	10.5%	Revenue: 1360824000 Open source Operating Cash Flow: 181725000 Open source Capital Expenditure: 39278000 Open source
20262026-03-28	Free cash flow margin	19.5%	Revenue: 1334027000 Open source Operating Cash Flow: 293221000 Open source Capital Expenditure: 32780000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 293.2M 2026

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20222022-04-02	Operating cash flow	172263000	Operating Cash Flow: 172263000 Open source
20232023-04-01	Operating cash flow	273058000	Operating Cash Flow: 273058000 Open source
20242024-03-30	Operating cash flow	181751000	Operating Cash Flow: 181751000 Open source
20252025-03-29	Operating cash flow	181725000	Operating Cash Flow: 181725000 Open source
20262026-03-28	Operating cash flow	293221000	Operating Cash Flow: 293221000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 260.4M 2026

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20222022-04-02	Free cash flow	75754000	Operating Cash Flow: 172263000 Open source Capital Expenditure: 96509000 Open source
20232023-04-01	Free cash flow	81731000	Operating Cash Flow: 273058000 Open source Capital Expenditure: 191327000 Open source
20242024-03-30	Free cash flow	143626000	Operating Cash Flow: 181751000 Open source Capital Expenditure: 38125000 Open source
20252025-03-29	Free cash flow	142447000	Operating Cash Flow: 181725000 Open source Capital Expenditure: 39278000 Open source
20262026-03-28	Free cash flow	260441000	Operating Cash Flow: 293221000 Open source Capital Expenditure: 32780000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2022-04-02	Liabilities / assets	Not reported	Total Assets: 1859734000 Open source
2023-04-01	Liabilities / assets	Not reported	Total Assets: 1934825000 Open source
2024-03-30	Liabilities / assets	Not reported	Total Assets: 2195591000 Open source
2025-03-29	Liabilities / assets	Not reported	Total Assets: 2450948000 Open source
2026-03-28	Liabilities / assets	Not reported	Total Assets: 2395925000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.95× 2026

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20222022-04-02	Current assets / current liabilities	1.71×	Current Assets: 756031000 Open source Current Liabilities: 442266000 Open source
20232023-04-01	Current assets / current liabilities	3.06×	Current Assets: 769722000 Open source Current Liabilities: 251816000 Open source
20242024-03-30	Current assets / current liabilities	2.56×	Current Assets: 768903000 Open source Current Liabilities: 300383000 Open source
20252025-03-29	Current assets / current liabilities	1.62×	Current Assets: 934975000 Open source Current Liabilities: 578113000 Open source
20262026-03-28	Current assets / current liabilities	2.95×	Current Assets: 834879000 Open source Current Liabilities: 282599000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2016-04-03 – 2017-04-01	−USD 26.27 million Exact value Exact value: -26268000 USD 2016-04-03 – 2017-04-01: -26268000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HAEMONETICS CORPORATION · 2017-04-01 HAEMONETICS CORPORATION (edgar:313143) Net Income: -26268000 USD Concept: fundies:NetIncome Period: 2016-04-03 to 2017-04-01 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ANetIncome&period=2017-04-01&surface=latest&period_type=duration&start=2016-04-03&unit=USD&dimensions= Input fundies:NetIncome: -26268000 USD (2016-04-03 to 2017-04-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314319000022/hae-20190330.xml#432428 Filing: 000031314319000022 The citation records this snapshot. The page link may show a newer release later.	USD 159.74 million Exact value Exact value: 159738000 USD 2016-04-03 – 2017-04-01: 159738000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HAEMONETICS CORPORATION · 2017-04-01 HAEMONETICS CORPORATION (edgar:313143) Operating Cash Flow: 159738000 USD Concept: fundies:OperatingCashFlow Period: 2016-04-03 to 2017-04-01 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3AOperatingCashFlow&period=2017-04-01&surface=latest&period_type=duration&start=2016-04-03&unit=USD&dimensions= Input fundies:OperatingCashFlow: 159738000 USD (2016-04-03 to 2017-04-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314319000022/hae-20190330.xml#431792 Filing: 000031314319000022 The citation records this snapshot. The page link may show a newer release later.	USD 76.14 million Exact value Exact value: 76135000 USD 2016-04-03 – 2017-04-01: 76135000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HAEMONETICS CORPORATION · 2017-04-01 HAEMONETICS CORPORATION (edgar:313143) Capital Expenditure: 76135000 USD Concept: fundies:CapitalExpenditure Period: 2016-04-03 to 2017-04-01 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ACapitalExpenditure&period=2017-04-01&surface=latest&period_type=duration&start=2016-04-03&unit=USD&dimensions= Input fundies:CapitalExpenditure: 76135000 USD (2016-04-03 to 2017-04-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314319000022/hae-20190330.xml#472182 Filing: 000031314319000022 The citation records this snapshot. The page link may show a newer release later.	USD 83.6 million Calculation and evidence 159738000 − 76135000 USD Exact free cash flow: 83603000 USD 2016-04-03 – 2017-04-01: 159738000 USD · Inspect Operating Cash Flow · Source 2016-04-03 – 2017-04-01: 76135000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HAEMONETICS CORPORATION · 2017-04-01 HAEMONETICS CORPORATION (edgar:313143) Free cash flow: 83603000 USD Concept: free-cash-flow Period: 2016-04-03 to 2017-04-01 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 159738000 USD (2016-04-03 to 2017-04-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314319000022/hae-20190330.xml#431792 Filing: 000031314319000022 Input fundies:CapitalExpenditure: 76135000 USD (2016-04-03 to 2017-04-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314319000022/hae-20190330.xml#472182 Filing: 000031314319000022 The citation records this snapshot. The page link may show a newer release later.
2018 2017-04-02 – 2018-03-31	USD 45.57 million Exact value Exact value: 45572000 USD 2017-04-02 – 2018-03-31: 45572000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HAEMONETICS CORPORATION · 2018-03-31 HAEMONETICS CORPORATION (edgar:313143) Net Income: 45572000 USD Concept: fundies:NetIncome Period: 2017-04-02 to 2018-03-31 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ANetIncome&period=2018-03-31&surface=latest&period_type=duration&start=2017-04-02&unit=USD&dimensions= Input fundies:NetIncome: 45572000 USD (2017-04-02 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314320000028/fy202010-kdocument.htm#2027952 Filing: 000031314320000028 The citation records this snapshot. The page link may show a newer release later.	USD 220.35 million Exact value Exact value: 220350000 USD 2017-04-02 – 2018-03-31: 220350000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HAEMONETICS CORPORATION · 2018-03-31 HAEMONETICS CORPORATION (edgar:313143) Operating Cash Flow: 220350000 USD Concept: fundies:OperatingCashFlow Period: 2017-04-02 to 2018-03-31 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3AOperatingCashFlow&period=2018-03-31&surface=latest&period_type=duration&start=2017-04-02&unit=USD&dimensions= Input fundies:OperatingCashFlow: 220350000 USD (2017-04-02 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314320000028/fy202010-kdocument.htm#1414442 Filing: 000031314320000028 The citation records this snapshot. The page link may show a newer release later.	USD 74.8 million Exact value Exact value: 74799000 USD 2017-04-02 – 2018-03-31: 74799000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HAEMONETICS CORPORATION · 2018-03-31 HAEMONETICS CORPORATION (edgar:313143) Capital Expenditure: 74799000 USD Concept: fundies:CapitalExpenditure Period: 2017-04-02 to 2018-03-31 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ACapitalExpenditure&period=2018-03-31&surface=latest&period_type=duration&start=2017-04-02&unit=USD&dimensions= Input fundies:CapitalExpenditure: 74799000 USD (2017-04-02 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314320000028/fy202010-kdocument.htm#1419172 Filing: 000031314320000028 The citation records this snapshot. The page link may show a newer release later.	USD 145.55 million Calculation and evidence 220350000 − 74799000 USD Exact free cash flow: 145551000 USD 2017-04-02 – 2018-03-31: 220350000 USD · Inspect Operating Cash Flow · Source 2017-04-02 – 2018-03-31: 74799000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HAEMONETICS CORPORATION · 2018-03-31 HAEMONETICS CORPORATION (edgar:313143) Free cash flow: 145551000 USD Concept: free-cash-flow Period: 2017-04-02 to 2018-03-31 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 220350000 USD (2017-04-02 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314320000028/fy202010-kdocument.htm#1414442 Filing: 000031314320000028 Input fundies:CapitalExpenditure: 74799000 USD (2017-04-02 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314320000028/fy202010-kdocument.htm#1419172 Filing: 000031314320000028 The citation records this snapshot. The page link may show a newer release later.
2019 2018-04-01 – 2019-03-30	USD 55.02 million Exact value Exact value: 55019000 USD 2018-04-01 – 2019-03-30: 55019000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HAEMONETICS CORPORATION · 2019-03-30 HAEMONETICS CORPORATION (edgar:313143) Net Income: 55019000 USD Concept: fundies:NetIncome Period: 2018-04-01 to 2019-03-30 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ANetIncome&period=2019-03-30&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:NetIncome: 55019000 USD (2018-04-01 to 2019-03-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314321000023/hae-20210403.htm#2083592 Filing: 000031314321000023 The citation records this snapshot. The page link may show a newer release later.	USD 159.28 million Exact value Exact value: 159281000 USD 2018-04-01 – 2019-03-30: 159281000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HAEMONETICS CORPORATION · 2019-03-30 HAEMONETICS CORPORATION (edgar:313143) Operating Cash Flow: 159281000 USD Concept: fundies:OperatingCashFlow Period: 2018-04-01 to 2019-03-30 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3AOperatingCashFlow&period=2019-03-30&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 159281000 USD (2018-04-01 to 2019-03-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314321000023/hae-20210403.htm#1266357 Filing: 000031314321000023 The citation records this snapshot. The page link may show a newer release later.	USD 118.96 million Exact value Exact value: 118961000 USD 2018-04-01 – 2019-03-30: 118961000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HAEMONETICS CORPORATION · 2019-03-30 HAEMONETICS CORPORATION (edgar:313143) Capital Expenditure: 118961000 USD Concept: fundies:CapitalExpenditure Period: 2018-04-01 to 2019-03-30 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ACapitalExpenditure&period=2019-03-30&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 118961000 USD (2018-04-01 to 2019-03-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314321000023/hae-20210403.htm#1270665 Filing: 000031314321000023 The citation records this snapshot. The page link may show a newer release later.	USD 40.32 million Calculation and evidence 159281000 − 118961000 USD Exact free cash flow: 40320000 USD 2018-04-01 – 2019-03-30: 159281000 USD · Inspect Operating Cash Flow · Source 2018-04-01 – 2019-03-30: 118961000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HAEMONETICS CORPORATION · 2019-03-30 HAEMONETICS CORPORATION (edgar:313143) Free cash flow: 40320000 USD Concept: free-cash-flow Period: 2018-04-01 to 2019-03-30 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 159281000 USD (2018-04-01 to 2019-03-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314321000023/hae-20210403.htm#1266357 Filing: 000031314321000023 Input fundies:CapitalExpenditure: 118961000 USD (2018-04-01 to 2019-03-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314321000023/hae-20210403.htm#1270665 Filing: 000031314321000023 The citation records this snapshot. The page link may show a newer release later.
2020 2019-03-31 – 2020-03-28	USD 76.53 million Exact value Exact value: 76526000 USD 2019-03-31 – 2020-03-28: 76526000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HAEMONETICS CORPORATION · 2020-03-28 HAEMONETICS CORPORATION (edgar:313143) Net Income: 76526000 USD Concept: fundies:NetIncome Period: 2019-03-31 to 2020-03-28 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ANetIncome&period=2020-03-28&surface=latest&period_type=duration&start=2019-03-31&unit=USD&dimensions= Input fundies:NetIncome: 76526000 USD (2019-03-31 to 2020-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314322000024/hae-20220402.htm#2023500 Filing: 000031314322000024 The citation records this snapshot. The page link may show a newer release later.	USD 158.22 million Exact value Exact value: 158217000 USD 2019-03-31 – 2020-03-28: 158217000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HAEMONETICS CORPORATION · 2020-03-28 HAEMONETICS CORPORATION (edgar:313143) Operating Cash Flow: 158217000 USD Concept: fundies:OperatingCashFlow Period: 2019-03-31 to 2020-03-28 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3AOperatingCashFlow&period=2020-03-28&surface=latest&period_type=duration&start=2019-03-31&unit=USD&dimensions= Input fundies:OperatingCashFlow: 158217000 USD (2019-03-31 to 2020-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314322000024/hae-20220402.htm#1233034 Filing: 000031314322000024 The citation records this snapshot. The page link may show a newer release later.	USD 48.76 million Exact value Exact value: 48758000 USD 2019-03-31 – 2020-03-28: 48758000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HAEMONETICS CORPORATION · 2020-03-28 HAEMONETICS CORPORATION (edgar:313143) Capital Expenditure: 48758000 USD Concept: fundies:CapitalExpenditure Period: 2019-03-31 to 2020-03-28 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ACapitalExpenditure&period=2020-03-28&surface=latest&period_type=duration&start=2019-03-31&unit=USD&dimensions= Input fundies:CapitalExpenditure: 48758000 USD (2019-03-31 to 2020-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314322000024/hae-20220402.htm#1237363 Filing: 000031314322000024 The citation records this snapshot. The page link may show a newer release later.	USD 109.46 million Calculation and evidence 158217000 − 48758000 USD Exact free cash flow: 109459000 USD 2019-03-31 – 2020-03-28: 158217000 USD · Inspect Operating Cash Flow · Source 2019-03-31 – 2020-03-28: 48758000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HAEMONETICS CORPORATION · 2020-03-28 HAEMONETICS CORPORATION (edgar:313143) Free cash flow: 109459000 USD Concept: free-cash-flow Period: 2019-03-31 to 2020-03-28 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 158217000 USD (2019-03-31 to 2020-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314322000024/hae-20220402.htm#1233034 Filing: 000031314322000024 Input fundies:CapitalExpenditure: 48758000 USD (2019-03-31 to 2020-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314322000024/hae-20220402.htm#1237363 Filing: 000031314322000024 The citation records this snapshot. The page link may show a newer release later.
2021 2020-03-29 – 2021-04-03	USD 79.47 million Exact value Exact value: 79469000 USD 2020-03-29 – 2021-04-03: 79469000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HAEMONETICS CORPORATION · 2021-04-03 HAEMONETICS CORPORATION (edgar:313143) Net Income: 79469000 USD Concept: fundies:NetIncome Period: 2020-03-29 to 2021-04-03 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ANetIncome&period=2021-04-03&surface=latest&period_type=duration&start=2020-03-29&unit=USD&dimensions= Input fundies:NetIncome: 79469000 USD (2020-03-29 to 2021-04-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314323000014/hae-20230401.htm#1945844 Filing: 000031314323000014 The citation records this snapshot. The page link may show a newer release later.	USD 108.81 million Exact value Exact value: 108805000 USD 2020-03-29 – 2021-04-03: 108805000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HAEMONETICS CORPORATION · 2021-04-03 HAEMONETICS CORPORATION (edgar:313143) Operating Cash Flow: 108805000 USD Concept: fundies:OperatingCashFlow Period: 2020-03-29 to 2021-04-03 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3AOperatingCashFlow&period=2021-04-03&surface=latest&period_type=duration&start=2020-03-29&unit=USD&dimensions= Input fundies:OperatingCashFlow: 108805000 USD (2020-03-29 to 2021-04-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314323000014/hae-20230401.htm#1166950 Filing: 000031314323000014 The citation records this snapshot. The page link may show a newer release later.	USD 37.04 million Exact value Exact value: 37040000 USD 2020-03-29 – 2021-04-03: 37040000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HAEMONETICS CORPORATION · 2021-04-03 HAEMONETICS CORPORATION (edgar:313143) Capital Expenditure: 37040000 USD Concept: fundies:CapitalExpenditure Period: 2020-03-29 to 2021-04-03 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ACapitalExpenditure&period=2021-04-03&surface=latest&period_type=duration&start=2020-03-29&unit=USD&dimensions= Input fundies:CapitalExpenditure: 37040000 USD (2020-03-29 to 2021-04-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314323000014/hae-20230401.htm#1171280 Filing: 000031314323000014 The citation records this snapshot. The page link may show a newer release later.	USD 71.77 million Calculation and evidence 108805000 − 37040000 USD Exact free cash flow: 71765000 USD 2020-03-29 – 2021-04-03: 108805000 USD · Inspect Operating Cash Flow · Source 2020-03-29 – 2021-04-03: 37040000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HAEMONETICS CORPORATION · 2021-04-03 HAEMONETICS CORPORATION (edgar:313143) Free cash flow: 71765000 USD Concept: free-cash-flow Period: 2020-03-29 to 2021-04-03 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 108805000 USD (2020-03-29 to 2021-04-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314323000014/hae-20230401.htm#1166950 Filing: 000031314323000014 Input fundies:CapitalExpenditure: 37040000 USD (2020-03-29 to 2021-04-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314323000014/hae-20230401.htm#1171280 Filing: 000031314323000014 The citation records this snapshot. The page link may show a newer release later.
2022 2021-04-04 – 2022-04-02	USD 43.38 million Exact value Exact value: 43375000 USD 2021-04-04 – 2022-04-02: 43375000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HAEMONETICS CORPORATION · 2022-04-02 HAEMONETICS CORPORATION (edgar:313143) Net Income: 43375000 USD Concept: fundies:NetIncome Period: 2021-04-04 to 2022-04-02 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ANetIncome&period=2022-04-02&surface=latest&period_type=duration&start=2021-04-04&unit=USD&dimensions= Input fundies:NetIncome: 43375000 USD (2021-04-04 to 2022-04-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314324000020/hae-20240330.htm#1606812 Filing: 000031314324000020 The citation records this snapshot. The page link may show a newer release later.	USD 172.26 million Exact value Exact value: 172263000 USD 2021-04-04 – 2022-04-02: 172263000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HAEMONETICS CORPORATION · 2022-04-02 HAEMONETICS CORPORATION (edgar:313143) Operating Cash Flow: 172263000 USD Concept: fundies:OperatingCashFlow Period: 2021-04-04 to 2022-04-02 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3AOperatingCashFlow&period=2022-04-02&surface=latest&period_type=duration&start=2021-04-04&unit=USD&dimensions= Input fundies:OperatingCashFlow: 172263000 USD (2021-04-04 to 2022-04-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314324000020/hae-20240330.htm#1099546 Filing: 000031314324000020 The citation records this snapshot. The page link may show a newer release later.	USD 96.51 million Exact value Exact value: 96509000 USD 2021-04-04 – 2022-04-02: 96509000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HAEMONETICS CORPORATION · 2022-04-02 HAEMONETICS CORPORATION (edgar:313143) Capital Expenditure: 96509000 USD Concept: fundies:CapitalExpenditure Period: 2021-04-04 to 2022-04-02 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ACapitalExpenditure&period=2022-04-02&surface=latest&period_type=duration&start=2021-04-04&unit=USD&dimensions= Input fundies:CapitalExpenditure: 96509000 USD (2021-04-04 to 2022-04-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314324000020/hae-20240330.htm#1102693 Filing: 000031314324000020 The citation records this snapshot. The page link may show a newer release later.	USD 75.75 million Calculation and evidence 172263000 − 96509000 USD Exact free cash flow: 75754000 USD 2021-04-04 – 2022-04-02: 172263000 USD · Inspect Operating Cash Flow · Source 2021-04-04 – 2022-04-02: 96509000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HAEMONETICS CORPORATION · 2022-04-02 HAEMONETICS CORPORATION (edgar:313143) Free cash flow: 75754000 USD Concept: free-cash-flow Period: 2021-04-04 to 2022-04-02 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 172263000 USD (2021-04-04 to 2022-04-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314324000020/hae-20240330.htm#1099546 Filing: 000031314324000020 Input fundies:CapitalExpenditure: 96509000 USD (2021-04-04 to 2022-04-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314324000020/hae-20240330.htm#1102693 Filing: 000031314324000020 The citation records this snapshot. The page link may show a newer release later.
2023 2022-04-03 – 2023-04-01	USD 115.4 million Exact value Exact value: 115401000 USD 2022-04-03 – 2023-04-01: 115401000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HAEMONETICS CORPORATION · 2023-04-01 HAEMONETICS CORPORATION (edgar:313143) Net Income: 115401000 USD Concept: fundies:NetIncome Period: 2022-04-03 to 2023-04-01 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ANetIncome&period=2023-04-01&surface=latest&period_type=duration&start=2022-04-03&unit=USD&dimensions= Input fundies:NetIncome: 115401000 USD (2022-04-03 to 2023-04-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314325000025/hae-20250329.htm#1712043 Filing: 000031314325000025 The citation records this snapshot. The page link may show a newer release later.	USD 273.06 million Exact value Exact value: 273058000 USD 2022-04-03 – 2023-04-01: 273058000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HAEMONETICS CORPORATION · 2023-04-01 HAEMONETICS CORPORATION (edgar:313143) Operating Cash Flow: 273058000 USD Concept: fundies:OperatingCashFlow Period: 2022-04-03 to 2023-04-01 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3AOperatingCashFlow&period=2023-04-01&surface=latest&period_type=duration&start=2022-04-03&unit=USD&dimensions= Input fundies:OperatingCashFlow: 273058000 USD (2022-04-03 to 2023-04-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314325000025/hae-20250329.htm#1140796 Filing: 000031314325000025 The citation records this snapshot. The page link may show a newer release later.	USD 191.33 million Exact value Exact value: 191327000 USD 2022-04-03 – 2023-04-01: 191327000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HAEMONETICS CORPORATION · 2023-04-01 HAEMONETICS CORPORATION (edgar:313143) Capital Expenditure: 191327000 USD Concept: fundies:CapitalExpenditure Period: 2022-04-03 to 2023-04-01 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ACapitalExpenditure&period=2023-04-01&surface=latest&period_type=duration&start=2022-04-03&unit=USD&dimensions= Input fundies:CapitalExpenditure: 191327000 USD (2022-04-03 to 2023-04-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314325000025/hae-20250329.htm#1143942 Filing: 000031314325000025 The citation records this snapshot. The page link may show a newer release later.	USD 81.73 million Calculation and evidence 273058000 − 191327000 USD Exact free cash flow: 81731000 USD 2022-04-03 – 2023-04-01: 273058000 USD · Inspect Operating Cash Flow · Source 2022-04-03 – 2023-04-01: 191327000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HAEMONETICS CORPORATION · 2023-04-01 HAEMONETICS CORPORATION (edgar:313143) Free cash flow: 81731000 USD Concept: free-cash-flow Period: 2022-04-03 to 2023-04-01 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 273058000 USD (2022-04-03 to 2023-04-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314325000025/hae-20250329.htm#1140796 Filing: 000031314325000025 Input fundies:CapitalExpenditure: 191327000 USD (2022-04-03 to 2023-04-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314325000025/hae-20250329.htm#1143942 Filing: 000031314325000025 The citation records this snapshot. The page link may show a newer release later.
2024 2023-04-02 – 2024-03-30	USD 117.56 million Exact value Exact value: 117558000 USD 2023-04-02 – 2024-03-30: 117558000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HAEMONETICS CORPORATION · 2024-03-30 HAEMONETICS CORPORATION (edgar:313143) Net Income: 117558000 USD Concept: fundies:NetIncome Period: 2023-04-02 to 2024-03-30 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ANetIncome&period=2024-03-30&surface=latest&period_type=duration&start=2023-04-02&unit=USD&dimensions= Input fundies:NetIncome: 117558000 USD (2023-04-02 to 2024-03-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1780322 Filing: 000031314326000050 The citation records this snapshot. The page link may show a newer release later.	USD 181.75 million Exact value Exact value: 181751000 USD 2023-04-02 – 2024-03-30: 181751000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HAEMONETICS CORPORATION · 2024-03-30 HAEMONETICS CORPORATION (edgar:313143) Operating Cash Flow: 181751000 USD Concept: fundies:OperatingCashFlow Period: 2023-04-02 to 2024-03-30 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3AOperatingCashFlow&period=2024-03-30&surface=latest&period_type=duration&start=2023-04-02&unit=USD&dimensions= Input fundies:OperatingCashFlow: 181751000 USD (2023-04-02 to 2024-03-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1151727 Filing: 000031314326000050 The citation records this snapshot. The page link may show a newer release later.	USD 38.13 million Exact value Exact value: 38125000 USD 2023-04-02 – 2024-03-30: 38125000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HAEMONETICS CORPORATION · 2024-03-30 HAEMONETICS CORPORATION (edgar:313143) Capital Expenditure: 38125000 USD Concept: fundies:CapitalExpenditure Period: 2023-04-02 to 2024-03-30 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ACapitalExpenditure&period=2024-03-30&surface=latest&period_type=duration&start=2023-04-02&unit=USD&dimensions= Input fundies:CapitalExpenditure: 38125000 USD (2023-04-02 to 2024-03-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1154842 Filing: 000031314326000050 The citation records this snapshot. The page link may show a newer release later.	USD 143.63 million Calculation and evidence 181751000 − 38125000 USD Exact free cash flow: 143626000 USD 2023-04-02 – 2024-03-30: 181751000 USD · Inspect Operating Cash Flow · Source 2023-04-02 – 2024-03-30: 38125000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HAEMONETICS CORPORATION · 2024-03-30 HAEMONETICS CORPORATION (edgar:313143) Free cash flow: 143626000 USD Concept: free-cash-flow Period: 2023-04-02 to 2024-03-30 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 181751000 USD (2023-04-02 to 2024-03-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1151727 Filing: 000031314326000050 Input fundies:CapitalExpenditure: 38125000 USD (2023-04-02 to 2024-03-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1154842 Filing: 000031314326000050 The citation records this snapshot. The page link may show a newer release later.
2025 2024-03-31 – 2025-03-29	USD 167.68 million Exact value Exact value: 167679000 USD 2024-03-31 – 2025-03-29: 167679000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HAEMONETICS CORPORATION · 2025-03-29 HAEMONETICS CORPORATION (edgar:313143) Net Income: 167679000 USD Concept: fundies:NetIncome Period: 2024-03-31 to 2025-03-29 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ANetIncome&period=2025-03-29&surface=latest&period_type=duration&start=2024-03-31&unit=USD&dimensions= Input fundies:NetIncome: 167679000 USD (2024-03-31 to 2025-03-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1779552 Filing: 000031314326000050 The citation records this snapshot. The page link may show a newer release later.	USD 181.73 million Exact value Exact value: 181725000 USD 2024-03-31 – 2025-03-29: 181725000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HAEMONETICS CORPORATION · 2025-03-29 HAEMONETICS CORPORATION (edgar:313143) Operating Cash Flow: 181725000 USD Concept: fundies:OperatingCashFlow Period: 2024-03-31 to 2025-03-29 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3AOperatingCashFlow&period=2025-03-29&surface=latest&period_type=duration&start=2024-03-31&unit=USD&dimensions= Input fundies:OperatingCashFlow: 181725000 USD (2024-03-31 to 2025-03-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1151073 Filing: 000031314326000050 The citation records this snapshot. The page link may show a newer release later.	USD 39.28 million Exact value Exact value: 39278000 USD 2024-03-31 – 2025-03-29: 39278000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HAEMONETICS CORPORATION · 2025-03-29 HAEMONETICS CORPORATION (edgar:313143) Capital Expenditure: 39278000 USD Concept: fundies:CapitalExpenditure Period: 2024-03-31 to 2025-03-29 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ACapitalExpenditure&period=2025-03-29&surface=latest&period_type=duration&start=2024-03-31&unit=USD&dimensions= Input fundies:CapitalExpenditure: 39278000 USD (2024-03-31 to 2025-03-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1154251 Filing: 000031314326000050 The citation records this snapshot. The page link may show a newer release later.	USD 142.45 million Calculation and evidence 181725000 − 39278000 USD Exact free cash flow: 142447000 USD 2024-03-31 – 2025-03-29: 181725000 USD · Inspect Operating Cash Flow · Source 2024-03-31 – 2025-03-29: 39278000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HAEMONETICS CORPORATION · 2025-03-29 HAEMONETICS CORPORATION (edgar:313143) Free cash flow: 142447000 USD Concept: free-cash-flow Period: 2024-03-31 to 2025-03-29 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 181725000 USD (2024-03-31 to 2025-03-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1151073 Filing: 000031314326000050 Input fundies:CapitalExpenditure: 39278000 USD (2024-03-31 to 2025-03-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1154251 Filing: 000031314326000050 The citation records this snapshot. The page link may show a newer release later.
2026 2025-03-30 – 2026-03-28	USD 97.31 million Exact value Exact value: 97308000 USD 2025-03-30 – 2026-03-28: 97308000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HAEMONETICS CORPORATION · 2026-03-28 HAEMONETICS CORPORATION (edgar:313143) Net Income: 97308000 USD Concept: fundies:NetIncome Period: 2025-03-30 to 2026-03-28 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ANetIncome&period=2026-03-28&surface=latest&period_type=duration&start=2025-03-30&unit=USD&dimensions= Input fundies:NetIncome: 97308000 USD (2025-03-30 to 2026-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1778783 Filing: 000031314326000050 The citation records this snapshot. The page link may show a newer release later.	USD 293.22 million Exact value Exact value: 293221000 USD 2025-03-30 – 2026-03-28: 293221000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HAEMONETICS CORPORATION · 2026-03-28 HAEMONETICS CORPORATION (edgar:313143) Operating Cash Flow: 293221000 USD Concept: fundies:OperatingCashFlow Period: 2025-03-30 to 2026-03-28 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3AOperatingCashFlow&period=2026-03-28&surface=latest&period_type=duration&start=2025-03-30&unit=USD&dimensions= Input fundies:OperatingCashFlow: 293221000 USD (2025-03-30 to 2026-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1150419 Filing: 000031314326000050 The citation records this snapshot. The page link may show a newer release later.	USD 32.78 million Exact value Exact value: 32780000 USD 2025-03-30 – 2026-03-28: 32780000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HAEMONETICS CORPORATION · 2026-03-28 HAEMONETICS CORPORATION (edgar:313143) Capital Expenditure: 32780000 USD Concept: fundies:CapitalExpenditure Period: 2025-03-30 to 2026-03-28 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143/explain?concept=fundies%3ACapitalExpenditure&period=2026-03-28&surface=latest&period_type=duration&start=2025-03-30&unit=USD&dimensions= Input fundies:CapitalExpenditure: 32780000 USD (2025-03-30 to 2026-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1153660 Filing: 000031314326000050 The citation records this snapshot. The page link may show a newer release later.	USD 260.44 million Calculation and evidence 293221000 − 32780000 USD Exact free cash flow: 260441000 USD 2025-03-30 – 2026-03-28: 293221000 USD · Inspect Operating Cash Flow · Source 2025-03-30 – 2026-03-28: 32780000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HAEMONETICS CORPORATION · 2026-03-28 HAEMONETICS CORPORATION (edgar:313143) Free cash flow: 260441000 USD Concept: free-cash-flow Period: 2025-03-30 to 2026-03-28 Values: Latest reported Published: 2026-11-02T23:13:20Z Snapshot: c3292f339ee375b2e7d36171689b84b7caaeac734284924c38a41ddbd71cfbb8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/313143?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 293221000 USD (2025-03-30 to 2026-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1150419 Filing: 000031314326000050 Input fundies:CapitalExpenditure: 32780000 USD (2025-03-30 to 2026-03-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm#1153660 Filing: 000031314326000050 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

185 filings · 6,518 latest values · 6,518 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000313143, 313143, HAE, edgar:313143

Also known as HAEMONETICS CORP, HAEMONETICS CORPORATION, Haemonetics Corporation

HAEMONETICS CORPORATION

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2026 2025-03-30 – 2026-03-28

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation